polymyxin b sulfate
PolandDrugs containing this active substance
-
It is used topically in cases of bacterial conjunctivitis, blepharitis, dacryocystitis, or keratitis, as well as after ocular surgical procedures (approximately 8-10 days after surgery). In laryngology, it helps with inflammation of the external auditory canal.
Form: drops, ophthalmic and otic, suspension
Active substance Dosage oxytetracycline hydrochloride 5 mg/ml polymyxin b sulfate 10000 IU.m/ml hydrocortisone acetate 15 mg ATC: S01CA03
Manufacturer: Jelfa Pharmaceutical Enterprise S.A.
-
The ointment is used in the treatment of dental pulp diseases (e.g., deep caries, inflammation) and periapical tissues.
Form: ointment
Active substance Dosage dexamethasone acetate 10 mg/g framycetin sulfate 25 mg/g polymyxin b sulfate 2.5 mg/g ATC: A01AD
Manufacturer: Chema-Elektromet Cooperative of Work
-
The medicine is used topically on the skin for minor wounds, such as abrasions, scratches, or bites, as well as for burns and skin ulcers.
Form: ointment
Active substance Dosage neomycin sulfate 5 mg zinc bacitracin 5000 j.m. polymyxin b sulfate 400 j.m. ATC: D06AX
Manufacturer: EMO-FARM Sp. z o.o.
-
The ointment is used to prevent secondary infections of minor wounds, scratches, abrasions, and burns, and to treat bacterial skin infections (e.g., in burns and frostbite).
Form: ointment
Active substance Dosage neomycin sulfate 5 mg zinc bacitracin 10 mg polymyxin b sulfate 0.833 mg ATC: D06AX
Manufacturer: Chema-Elektromet Cooperative of Work
-
It is used for minor wounds, such as abrasions, scratches, or bites, as well as for burns and skin ulcers.
Form: ointment
Active substance Dosage neomycin sulfate 5.0 mg/1 g polymyxin b sulfate 5000 j.m./1 g zinc bacitracin 400 j.m./1 g ATC: D06AX
Manufacturer: Aflofarm Farmacja Polska Limited
-
It is intended to prevent bacterial infections in the case of minor wounds, scratches, and burns.
Form: ointment
Active substance Dosage zinc bacitracin 10 mg neomycin sulfate 5 mg polymyxin b sulfate 0.833 mg ATC: D06AX05
Manufacturer: Kato Labs Sp. z o.o. Tarchomin Pharmaceutical Works "Polfa" S.A.